Regulation of salivary gland inflammation in Sjogren's Syndrome by Annexin 1
Regulation of salivary gland inflammation in Sjogren's Syndrome by Annexin 1
批准号:
9809545
负责人:
Markus Hardt
金额:
$24.88万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-07-01 至 2021-06-30
关键词:
AgeAnnexin A1AnnexinsAnti-inflammatoryApoptosisApplications GrantsAutoimmune ResponsesAutoimmunityBindingBiological AssayBiologyCellsCharacteristicsChronicClinicalDataDevelopmentDiagnosisDiseaseEventExperimental ModelsFPR2 geneFlow CytometryFunctional disorderGene ExpressionGlucocorticoidsGoalsHistologyHistopathologyImmuneImmunoassayImmunohistochemistryImmunologyInbred NOD MiceInfiltrationInflammationInflammatoryInjectionsKnowledgeLacrimal gland structureLeukocyte ElastaseLeukocytesLymphocyteMeasuresMissionModelingMolecularMolecular ConformationMonitorN-terminalNatural ImmunityNecrosisPI3 genePathologyPatientsPeptide HydrolasesPeptidesPlayPreventive treatmentProcessPropertyProtease InhibitorProteinase 3ProteinsProteolysisProteolytic ProcessingProteomicsPublic HealthQuality of lifeRecombinantsRegulationResearchResistanceResolutionReverse Transcriptase Polymerase Chain ReactionRheumatismRoleSalivaSalivarySalivary GlandsSeverity of illnessSiteSjogren&aposs SyndromeSymptomsT cell responseT-LymphocyteTestingTherapeuticTissuesTumor-infiltrating immune cellsUnited States National Institutes of HealthWorkXerostomiaadaptive immunityautoimmune uveitisautoreactivitybaseeffective therapyelastase inhibitorexperienceextracellulareye drynessin vivoinflammatory markerinsightmimeticsmouse modelnovelpharmacophorepreservationpreventspecific biomarkerssystemic autoimmune disease
中文摘要
项目摘要
本提案的目的是研究抗炎和促消退蛋白的具体作用
膜联蛋白A1(AnxA 1)在干燥综合征(SjS)的发展和发病过程中,
主要针对唾液腺和泪腺的风湿性疾病,导致临床上的眼干和口干
症状SjS的病理生理事件与异常蛋白水解密切相关。该提案
假设SJS相关的蛋白水解加工改变了抗炎和促消退特性,
AnxA1尽管AnxA 1的缺失与不受控制的增殖和自身反应性免疫缺陷的激活有关,
Th 17细胞在实验性自身免疫性葡萄膜炎小鼠模型中的作用,
AnxA 1在SjS病发病过程中的作用在我们的初步研究中,我们发现了N-末端的切割产物,
AnxA 1的区域,具有AnxA 1抗炎特性的主要药效团。目标1将
确定用N-末端AnxA 1肽ac 2 -26进行预防性治疗是否会减轻炎症,
在NOD小鼠模型中调节T细胞应答并防止唾液腺破坏。目标2将评估
AnxA 1保护性蛋白酶抑制剂对NOD小鼠SjS发展和发病的影响。结果
这项研究将提供关键的见解AnxA 1在调节自身免疫反应的作用,
促进SjS的解决,并提出新的机制衍生的诊断和控制策略
炎症和组织功能障碍和破坏。
英文摘要
PROJECT SUMMARY
This objective of this proposal is to examine the specific role of the anti-inflammatory and pro-resolving protein
Annexin A1 (AnxA1) during the development and onset of Sjögren's Syndrome (SjS), the second most common
rheumatic disease that primarily targets the salivary and lacrimal glands causing clinical dry eye and dry mouth
symptoms. Pathophysiological events in SjS are strongly associated with aberrant proteolysis. The proposal
hypothesizes that SjS-associated proteolytic processing alter the anti-inflammatory and pro-resolution properties
of AnxA1. While loss of AnxA1 has been associated with uncontrolled proliferation and activation of autoreactive
Th17 cells in the mouse model of experimental autoimmune uveitis, there is a critical knowledge gap about
AnxA1 in the SjS disease process. In our preliminary studies, we discovered cleavage products of the N-terminal
region of AnxA1 that harbors the main pharmacophore for the anti-inflammatory properties of AnxA1. Aim 1 will
determine whether preventive treatment with N-terminal AnxA1 peptide ac2-26 will reduce inflammation,
modulate T cell response and prevent salivary gland destruction in the NOD mouse model. Aim 2 will evaluate
the effect of AnxA1-protective protease inhibitors on the development and onset of SjS in NOD mice. Results
from this study will provide critical insights into the role of AnxA1 in modulating autoimmune response and
promote resolution in SjS and suggest novel mechanism-derived strategies for diagnosis and controlling
inflammation and tissue dysfunction and destruction in SjS.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Role of Proteases and Peptides in Cancer Pain
-
批准号:8141367
-
项目类别:
-
资助金额:$55.05万
-
财政年份:2010
-
负责人:Markus Hardt
-
依托单位:
The Role of Proteases and Peptides in Cancer Pain
-
批准号:8292511
-
项目类别:
-
资助金额:$37.07万
-
财政年份:2010
-
负责人:Markus Hardt
-
依托单位:
The Role of Proteases and Peptides in Cancer Pain
-
批准号:8319268
-
项目类别:
-
资助金额:$43.95万
-
财政年份:2010
-
负责人:Markus Hardt
-
依托单位:
The Role of Proteases and Peptides in Cancer Pain
-
批准号:8517250
-
项目类别:
-
资助金额:$4.24万
-
财政年份:2010
-
负责人:Markus Hardt
-
依托单位:
The Role of Proteases and Peptides in Cancer Pain
-
批准号:8519104
-
项目类别:
-
资助金额:$46.15万
-
财政年份:2010
-
负责人:Markus Hardt
-
依托单位:
The Role of Proteases and Peptides in Cancer Pain
-
批准号:8725967
-
项目类别:
-
资助金额:$43.95万
-
财政年份:2010
-
负责人:Markus Hardt
-
依托单位:
国内基金
海外基金
登录
查看更多内容
靶向Annexin A1蛋白预防CAR-T细胞治疗后BCMA阴性多发性骨髓瘤复发的机制研究
-
批准号:82370201
-
项目类别:面上项目
-
资助金额:48万元
-
批准年份:2023
-
负责人:许捷
-
依托单位:
Annexin A1通过IFN-γ通路正向调控PD-L1介导肺腺癌免疫逃逸的机制研究
-
批准号:82172716
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:夏曙
-
依托单位:
外源性尿酸调控SP1-Annexin a1在大鼠肝性脑病中的保护作用及机制研究
-
批准号:82060128
-
项目类别:地区科学基金项目
-
资助金额:34.0万元
-
批准年份:2020
-
负责人:程翅
-
依托单位:
Annexin A1 调控 Notch1/Smad2/p15 信号轴促进急性髓系白血病细胞增殖的机制研究
-
批准号:81770176
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2017
-
负责人:付彩云
-
依托单位:
Annexin A1通过调控TGF-β 受体内吞促进人卵巢癌细胞增殖的机制研究
-
批准号:81672577
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2016
-
负责人:张双
-
依托单位:
膜联蛋白Annexin A1与Annexin A7在脑出血后继发性脑损伤中的作用机制研究
-
批准号:81571115
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2015
-
负责人:王中
-
依托单位:
Annexin A1对婴幼儿体外循环术后急性肺损伤的保护研究
-
批准号:81400309
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2014
-
负责人:洪小杨
-
依托单位:
哺乳动物雷帕霉素靶蛋白(mTOR)介导膜联蛋白A1(Annexin A1)调控衰老相关胰岛β细胞功能下降的研究
-
批准号:81300265
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:谷昭艳
-
依托单位:
Annexin A1在头颈鳞癌EGF相关ERK/MAPK信号通路中的作用机制
-
批准号:81272979
-
项目类别:面上项目
-
资助金额:65.0万元
-
批准年份:2012
-
负责人:钟来平
-
依托单位:
Annexin A1表达下调/缺失在鼻咽癌放疗抵抗中的作用及其分子机制研究
-
批准号:81272959
-
项目类别:面上项目
-
资助金额:78.0万元
-
批准年份:2012
-
负责人:曾谷清
-
依托单位: